Skip to main content
. 2022 Jul 5;2(4):100192. doi: 10.1016/j.xops.2022.100192

Table 2.

Key Points Identified by Past Research on AMD

  • 1.

    AMD is a complex, multifactorial disease that likely involves contributions from multiple pathologic processes that lead to photoreceptor death and blindness.

  • 2.

    Cell-based models have their value but have inherent limitations because of their inability to capture the complexity of the human retina.

  • 3.

    Rodent animal models, although helpful, have major limitations in their ability to model human disease given their lack of macula in addition to being rod photoreceptor-dominant, nocturnal animals.

  • 4.

    Anti-VEGF agents have taught us that multiple diseases with heterogeneous underlying etiologies can be managed successfully with a common approach if they share a critical, common process.

  • 5.

    Lessons from diverse neurodegenerative diseases, including beyond the eye, may be applicable to AMD and may lead unifying therapies that have widespread effects.

AMD = age-related macular degeneration.